30 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Orphan designation status
Negative Remove Negative filter
-
List item
Orphan designation: melatonin for: Treatment of partial deep dermal and full-thickness burns
Date of first decision: 13/03/2018, Negative, Last updated: 11/04/2018 -
List item
Orphan designation: 20% Intravenous fat emulsion consisting of 20% soybean oil, 1.2% egg yolk phospholipids, 2.25% glycerin, and water for injection for: Treatment of poisoning by local anaesthetics
Date of first decision: 03/04/2017, Negative, Last updated: 15/05/2017 -
List item
Orphan designation: 3-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine hydrochloride for: Treatment of narcolepsy
Date of first decision: 13/07/2016, Negative, Last updated: 09/01/2017 -
List item
Orphan designation: Naltrexone for: Treatment of fibromyalgia
Date of first decision: 06/10/2016, Negative, Last updated: 13/12/2016 -
List item
Orphan designation: Nalbuphine hydrochloride for: Treatment of uraemic pruritus
Date of first decision: 27/02/2015, Negative, Last updated: 02/10/2015 -
List item
Orphan designation: 5-chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine for: Treatment of non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive
Date of first decision: 28/03/2014, Negative, Last updated: 10/03/2015 -
List item
Orphan designation: Sodium ascorbate and menadione sodium bisulfite for: Treatment of autosomal dominant polycystic kidney disease
Date of first decision: 11/12/2014, Negative, Last updated: 10/03/2015 -
List item
Orphan designation: zoledronic acid for: Treatment of complex regional pain syndrome
Date of first decision: 17/04/2013, Negative, Last updated: 23/04/2013 -
List item
Orphan designation: Tariquidar for: treatment of P-gp positive breast cancer
Date of first decision: 21/03/2012, Negative, Last updated: 06/09/2012 -
List item
Orphan designation: Lentiviral vector expressing the truncated form of human tyrosine hydroxylase gene, human aromatic L amino-acid decarboxylase gene, human GTP-cyclohydrolase 1 gene for: Treatment of off-periods in adult patients with advanced Parkinson's disease
Date of first decision: 09/09/2010, Negative, Last updated: 30/03/2012 -
List item
Orphan designation: Nabilone for: Treatment of amyotrophic lateral sclerosis
Date of first decision: 16/01/2011, Negative, Last updated: 20/12/2011 -
List item
Orphan designation: Molgramostim for: Treatment of cystic fibrosis
Date of first decision: 16/07/2010, Negative, Last updated: 09/08/2010 -
List item
Orphan designation: Gastrin 17C diphtheria toxoid conjugate for: Treatment of pancreatic cancer
Date of first decision: 16/07/2010, Negative, Last updated: 05/08/2010 -
List item
Orphan designation: 4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl]tetrahydro-N-hydroxy-2H-pyran-4-carboxamide for: Prevention of graft rejection after liver transplantation
Date of first decision: 10/09/2008, Negative, Last updated: 30/10/2009 -
List item
Orphan designation: Ibritumomab tiuxetan for use with 90Yttrium for: Treatment of B-cell non-Hodgkin`s lymphoma
Date of first decision: 01/02/2002, Negative, Last updated: 17/09/2009 -
List item
Orphan designation: Chelidonii radix special liquid extract for: Treatment of pancreatic cancer
Date of first decision: 04/12/2007, Negative, Last updated: 29/07/2008 -
List item
Orphan designation: capsaicin for: Treatment of painful HIV-associated neuropathy
Date of first decision: 21/09/2006, Negative, Last updated: 19/07/2007 -
List item
Orphan designation: Tramadol hydrochloride for: Treatment of painful HIV-associated neuropathy
Date of first decision: 21/09/2006, Negative, Last updated: 19/07/2007 -
List item
Orphan designation: Midazolam Hydrochloride for: Treatment of status epilepticus
Date of first decision: 01/03/2004, Negative, Last updated: 12/12/2005 -
List item
Orphan designation: Sudismase for: Treatment of active phase of Peyronie's disease
Date of first decision: 16/06/2005, Negative, Last updated: 27/10/2005 -
List item
Orphan designation: Ibuprofen L-Lysinate (salt) for: Treatment of patent ductus arteriosus in premature neonates of less than 34 week gestational age
Date of first decision: 24/06/2005, Negative, Last updated: 11/10/2005 -
List item
Orphan designation: Ibuprofen L-Lysinate (salt) for: Prevention of patent ductus arteriosus in premature neonates of less than 34 week of gestational age
Date of first decision: 07/07/2005, Negative, Last updated: 11/10/2005 -
List item
Orphan designation: Histamine dihydrochloride for: Treatment of malignant melanoma
Date of first decision: 24/08/2004, Negative, -
List item
Orphan designation: Mycobacterial cell wall complex for: Treatment of carcinoma in situ of the urinary bladder
Date of first decision: 18/12/2002, Negative, Last updated: 14/01/2003 -
List item
Orphan designation: Chlorproguanil hydrochloride and dapsone for: Treatment of acute uncomplicated plasmodium falciparum malaria
Date of first decision: 26/07/2002, Negative,